These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Current and Future Landscape in Genetic Therapies for Leber Hereditary Optic Neuropathy. Shamsnajafabadi H; MacLaren RE; Cehajic-Kapetanovic J Cells; 2023 Aug; 12(15):. PubMed ID: 37566092 [TBL] [Abstract][Full Text] [Related]
5. Current and Emerging Treatment Modalities for Leber's Hereditary Optic Neuropathy: A Review of the Literature. Theodorou-Kanakari A; Karampitianis S; Karageorgou V; Kampourelli E; Kapasakis E; Theodossiadis P; Chatziralli I Adv Ther; 2018 Oct; 35(10):1510-1518. PubMed ID: 30173326 [TBL] [Abstract][Full Text] [Related]
6. Leber hereditary optic neuropathy: new and emerging therapies. Davila-Siliezar P; Carter M; Milea D; Lee AG Curr Opin Ophthalmol; 2022 Nov; 33(6):574-578. PubMed ID: 36066375 [TBL] [Abstract][Full Text] [Related]
7. Genetic variants affecting NQO1 protein levels impact the efficacy of idebenone treatment in Leber hereditary optic neuropathy. Aleo SJ; Del Dotto V; Romagnoli M; Fiorini C; Capirossi G; Peron C; Maresca A; Caporali L; Capristo M; Tropeano CV; Zanna C; Ross-Cisneros FN; Sadun AA; Pignataro MG; Giordano C; Fasano C; Cavaliere A; Porcelli AM; Tioli G; Musiani F; Catania A; Lamperti C; Marzoli SB; De Negri A; Cascavilla ML; Battista M; Barboni P; Carbonelli M; Amore G; La Morgia C; Smirnov D; Vasilescu C; Farzeen A; Blickhaeuser B; Prokisch H; Priglinger C; Livonius B; Catarino CB; Klopstock T; Tiranti V; Carelli V; Ghelli AM Cell Rep Med; 2024 Feb; 5(2):101383. PubMed ID: 38272025 [TBL] [Abstract][Full Text] [Related]
8. Is Leber hereditary optic neuropathy treatable? Encouraging results with idebenone in both prospective and retrospective trials and an illustrative case. Sabet-Peyman EJ; Khaderi KR; Sadun AA J Neuroophthalmol; 2012 Mar; 32(1):54-7. PubMed ID: 22269948 [TBL] [Abstract][Full Text] [Related]
13. Idebenone: A Review in Leber's Hereditary Optic Neuropathy. Lyseng-Williamson KA Drugs; 2016 May; 76(7):805-13. PubMed ID: 27071925 [TBL] [Abstract][Full Text] [Related]
14. Dominant Optic Atrophy and Leber's Hereditary Optic Neuropathy: Update on Clinical Features and Current Therapeutic Approaches. Chun BY; Rizzo JF Semin Pediatr Neurol; 2017 May; 24(2):129-134. PubMed ID: 28941528 [TBL] [Abstract][Full Text] [Related]
15. Evaluating the therapeutic potential of idebenone and related quinone analogues in Leber hereditary optic neuropathy. Yu-Wai-Man P; Soiferman D; Moore DG; Burté F; Saada A Mitochondrion; 2017 Sep; 36():36-42. PubMed ID: 28093355 [TBL] [Abstract][Full Text] [Related]
16. Use of mitochondrial antioxidant defenses for rescue of cells with a Leber hereditary optic neuropathy-causing mutation. Qi X; Sun L; Hauswirth WW; Lewin AS; Guy J Arch Ophthalmol; 2007 Feb; 125(2):268-72. PubMed ID: 17296905 [TBL] [Abstract][Full Text] [Related]
17. International Consensus Statement on the Clinical and Therapeutic Management of Leber Hereditary Optic Neuropathy. Carelli V; Carbonelli M; de Coo IF; Kawasaki A; Klopstock T; Lagrèze WA; La Morgia C; Newman NJ; Orssaud C; Pott JWR; Sadun AA; van Everdingen J; Vignal-Clermont C; Votruba M; Yu-Wai-Man P; Barboni P J Neuroophthalmol; 2017 Dec; 37(4):371-381. PubMed ID: 28991104 [TBL] [Abstract][Full Text] [Related]